VS
BMO Equal Weight U.S. Health Care Index ETF (ZUH) and Harvest Healthcare Leaders Income ETF (HHL) offer distinct profiles for Canadian ETF investors. A direct comparison shows that ZUH focuses its top 3 sector exposures on Healthcare, while HHL leans towards Healthcare and Sovereign. When evaluating costs, ZUH features a management fee (MER) of 0.35%, compared to 0.85% for HHL. Performance-wise, ZUH has returned 12.14% year-to-date with -$17 M in net flows, whereas HHL is at 0.42% with +$362 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
ZUH
HHL
| AuM | $184.40 M | $1,854.43 M |
| Management Fees | 0.35% | 0.85% |
| Exp. ratio | 0.39% | 0.98% |
| Tracking Difference | -0.29% | - |
Historical performance and flows
As of September 15, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | ZUH | +2.12% | +13.21% | +12.14% | +22.55% | +18.87% |
HHL | -2.01% | +7.33% | +0.42% | +11.61% | +19.91% | |
| Flows | ZUH | +$0 M | -$7 M | -$17 M | -$27 M | -$178 M |
HHL | +$9 M | +$48 M | +$362 M | +$364 M | +$693 M |
ZUH vs HHL exposure
Countries
ZUH
USA
94.00%
HHL
USA
84.21%
Other
15.79%
Sectors
ZUH
Healthcare
98.86%
HHL
Healthcare
98.89%
As of September 15, 2026
Top 10 Holdings
ZUH
Humana, Inc.
2.31%
Revolution Medicines, Inc.
2.20%
Guardant Health, Inc.
1.89%
Illumina, Inc.
1.86%
DaVita, Inc.
1.79%
Baxter International, Inc.
1.71%
UnitedHealth Group, Inc.
1.66%
Neurocrine Biosciences, Inc.
1.63%
Jazz Pharmaceuticals Plc
1.61%
Centene Corp.
1.57%
HHL
Regeneron Pharmaceuticals, Inc.
5.34%
Boston Scientific Corp.
5.14%
Bristol Myers Squibb Co.
5.10%
Thermo Fisher Scientific, Inc.
5.00%
Merck & Co., Inc.
4.99%
Elevance Health, Inc.
4.99%
Amgen, Inc.
4.95%
Agilent Technologies, Inc.
4.95%
Intuitive Surgical, Inc.
4.94%
UnitedHealth Group, Inc.
4.94%
Diversification
ZUH
Total weight of top 10 holdings out of 79 total
18.21%
HHL
Total weight of top 10 holdings out of 25 total
50.34%
Characteristics
Compare
ZUH
HHL
| Provider | BMO | Harvest Portfolios Group |
| Management | Passively managed | Actively managed |
| Benchmark | Solactive Equal Weight US Health Care Canadian Dollar Hedged Total Return Index - CAD | - |
| Replication Method | Direct (Physical) | |
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 0.49% | 9.95% |
| Meets ESG criteria | No | No |
| Inception Date | May 19, 2010 | December 18, 2014 |
Frequently asked questions about ZUH and HHL
Which ETF has performed better year to date: ZUH or HHL?
As of September 15, 2026, ZUH has returned 12.14% year to date, while HHL has returned 0.42%. ZUH is ahead on YTD performance.
Which ETF is larger by assets under management: ZUH or HHL?
As of September 15, 2026, ZUH manages $184.40 M in assets, while HHL manages $1.85 B. HHL is the larger fund by AUM.
How are ZUH and HHL managed?
ZUH is passively managed by BMO. It tracks the Solactive Equal Weight US Health Care Canadian Dollar Hedged Total Return Index - CAD benchmark. HHL is actively managed by Harvest Portfolios Group. It does not track an index.
What sectors do ZUH and HHL emphasize?
ZUH is most exposed to Healthcare. HHL is most exposed to Healthcare and Sovereign.
Which ETF is attracting more investor flows: ZUH or HHL?
Year to date, ZUH has seen -$17.22 M in net flows, compared with +$361.73 M for HHL. HHL has attracted more net investor money so far.
How do the fees of ZUH and HHL compare?
ZUH has an expense ratio of 0.39%, while HHL has an expense ratio of 0.98%.
What are the top holdings of ZUH and HHL?
ZUH's largest holdings include Humana, Inc., Revolution Medicines, Inc., and Guardant Health, Inc.. HHL's top holdings include Regeneron Pharmaceuticals, Inc., Boston Scientific Corp., and Bristol Myers Squibb Co..
Which ETF is more diversified: ZUH or HHL?
ZUH holds 79 securities, while HHL holds 25. On holdings count, ZUH is the more diversified portfolio.
Recent articles about ZUH and HHL
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.